ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

BOLD MRI to Evaluate the Effects of Sacubitril/Valsartan on Renal Protection in Type 2 Diabetics.

Limin Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.